Showing results (461-470 of 2,911) with videos related to

Sort By:
Pageof 292
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Alternative p38 MAPKs are essential for collagen-induced arthritisGabriel Criado, Ana Risco, Dayanira Alsina-Beauchamp, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Long-term outcome of neuro-Behçet's diseaseNicolas Noel, Remy Bernard, Bertrand Wechsler, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Poor sleep quality is strongly associated with subsequent pain intensity in patients with acute low back painSaad M Alsaadi, James H McAuley, Julia M Hush, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled TrialIlan Ben-Zvi, Olga Kukuy, Eitan Giat, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Different Rating of Global Rheumatoid Arthritis Disease Activity in Rheumatoid Arthritis Patients With Multiple MorbiditiesHelga Radner, Kazuki Yoshida, Sara Tedeschi, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2016
Brief Report: Functional Interaction of Endoplasmic Reticulum Aminopeptidase 2 and HLA-B27 Activates the Unfolded Protein ResponseZhenbo Zhang, Francesco Ciccia, Fanxing Zeng, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2016
Effects of Baricitinib on Lipid, Apolipoprotein, and Lipoprotein Particle Profiles in a Phase IIb Study of Patients With Active Rheumatoid ArthritisJoel M Kremer, Mark C Genovese, Edward Keystone, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 21, 2017
Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled StudyFrancisco J Blanco, Rüdiger Möricke, Eva Dokoupilova, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 21, 2017
Brief Report: Anti-RNPC-3 Antibodies As a Marker of Cancer-Associated SclerodermaAmi A Shah, George Xu, Antony Rosen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 16, 2017
Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's SyndromeSimon J Bowman, Colin C Everett, John L O'Dwyer, et al.
Pageof 292